CARNITINE

Brand Owner (click to sort) Address Description
CARNIPLAIN MITSUBISHI RAYON KABUSHIKI KAISHA (trading also as MITSUBISHI RAYON CO., LTD.) 1-1, Marunouchi 1 Chome, Japan Carnitine, its salts and derivatives for pharmaceutical purpose, namely, for diet, regulation of heart rate, regulation of systolic arterial pressure, prevention and treatment of hypercholesterolemia, prevention and treatment of hypertriglyceridemia, improvement of anti-fatigue action, improvement of stamina, improvement of renal function, improvement of sperm-activation, prevention and treatment of demented state, prevention and treatment of diabetes, prevention and treatment of Alzheimer's disease, prevention and treatment of hyperthyroidism, prevention and treatment of anemia, prevention and treatment of cardiovascular disease, prevention and treatment of hepatic disease, and prevention and treatment of secondary carnitine deficiency syndromes;CARNITINE PLAIN;Color is not claimed as a feature of the mark.;Carnitine, its salts and derivates for use in the manufacture of pharmaceutical preparations and dietetic foodstuffs;The wording CARNIPLAIN appearing in the mark has no meaning in a foreign language.;
CARNIPLAIN MITSUBISHI RAYON KABUSHIKI KAISHA (alsotrading as; Mitsubishi Rayon Co., Ltd.) 6-41, Konan 1-Chome Minato-Ku; Tokyo 108-8506 Japan Carnitine, its salts and derivatives for pharmaceutical purpose, namely, for diet, regulation of heart rate, regulation of systolic arterial pressure, prevention and treatment of hypercholesterolemia, prevention and treatment of hypertriglyceridemia, improvement of anti-fatigue action, improvement of stamina, improvement of renal function, improvement of sperm-activation, prevention and treatment of demented state, prevention and treatment of diabetes, prevention and treatment of Alzheimer's disease, prevention and treatment of hyperthyroidism, prevention and treatment of anemia, prevention and treatment of cardiovascular disease, prevention and treatment of hepatic disease, and prevention and treatment of secondary carnitine deficiency syndromes;CARNITINE PLAIN;Color is not claimed as a feature of the mark.;Carnitine, its salts and derivates for use in the manufacture of pharmaceutical preparations and dietetic foodstuffs;The wording CARNIPLAIN appearing in the mark has no meaning in a foreign language.;
CARNIPURE Lonza Ltd Lonzastrasse CH-3930 Visp Switzerland Carnitine, its salts and derivatives for pharmaceutical purposes, namely, for the treatment of primary systemic carnitine deficiency and secondary carnitine deficiency syndromes;CARNITINE PURE;Carnitine, its salts and derivatives for use in the manufacture of pharmaceutical preparations, dietetic substances and foodstuffs;
CARNIPURE LONZA LTD. Lonzastrasse Visp 3930 Switzerland Carnitine, its salts and derivatives for use in the manufacture of hair care, skin care and cosmetic applications;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method for preparing, from at least one hygroscopic substance, mixtures that can be granulated and that have little hygroscopicity. The corresponding mixtures, especially carnitine-magnesium citrate and carnitine-magnesium hydroxycitrate, are produced.